Clinical Trials Directory

Trials / Completed

CompletedNCT06211465

Cardiovascular And Metabolic Risk After Arthroplasty

Cardiovascular And Metabolic Risk After Arthroplasty: the CAMERA Study

Status
Completed
Phase
Study type
Observational
Enrollment
152 (actual)
Sponsor
University of Tartu · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Osteoarthritis is a chronic joint disease that lacks curative therapy. Epidemiological studies show increase in the burden of disease. Total joint arthroplasty is one of the best treatment options for end-stage osteoarthritis. However, the specific effects of total joint arthroplasty on cardiovascular risk and metabolic profile are largely unknown. The aim of this project is to elucidate how hip and knee total joint arthroplasty impacts cardiovascular risk and metabolomic profile in comparison with general population. We hypothesize that arthroplasty decreases pain, systemic inflammation levels and increases functional status that all lead to decreased metabolic and cardiovascular risk.

Conditions

Interventions

TypeNameDescription
PROCEDURETotal joint arthroplastyHip or knee total joint arthroplasty

Timeline

Start date
2014-03-01
Primary completion
2023-01-01
Completion
2023-04-01
First posted
2024-01-18
Last updated
2024-01-18

Locations

1 site across 1 country: Estonia

Source: ClinicalTrials.gov record NCT06211465. Inclusion in this directory is not an endorsement.